Company Overview and News

How Precious Metals and Miners Moving in April?

9h marketrealist
Precious metals had another up day as gold futures for April expiration rose 0.48% on Friday, April 13, closing at $1,344.80 per ounce. Silver rose 1.1%, ending the day at $16.60 per ounce.
Upvote Downvote

A Look at Miners’ Volatility in April 2018

2018-04-17 marketrealist
The recent unrest in the markets has had a significant effect on precious metals and mining companies. The US dollar has a prominent role in influencing dollar-denominated precious metals and mining stocks.
Upvote Downvote

Geopolitical Tensions and Volatility: Impact on the Market

2018-04-17 marketrealist
Geopolitical tensions, trade war fears, rate hikes, and market volatility have left investors restless. Geopolitical issues started when President Trump imposed tariffs on steel and aluminum imports. The issues increased due to a potential trade war between the United States and China. Next, President Trump targeted Russia. Sanctions have been imposed on several Russian entities, including aluminum giant RUSAL.
Upvote Downvote

How Fed’s March Meeting Minutes Could Affect Gold Outlook

2018-04-16 marketrealist
The Fed minutes from its policy meeting on March 20–21 were released on April 11, 2018. These minutes were slightly more hawkish than expected. In the March meeting minutes, the FOMC (Federal Open Market Committee) staff review of the economy was stronger than the review presented at the January meeting. The short-term real GDP growth expectation was revised lower due to softness in recent economic data.
Upvote Downvote

How Are Miners’ Technicals Moving amid the Revival?

2018-04-12 marketrealist
Recently, the unrest in the markets has had a significant effect on precious metals and the US dollar. The US dollar has a prominent role in influencing dollar-denominated precious metals and mining stocks.
Upvote Downvote

Bed, Bath & Beyond, Dominion Topple into Thursday’s 52-Week Low Club

2018-04-12 247wallst
April 12, 2018: Here are four stocks trading with heavy volume among 42 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by less than 8 to 7 and on the Nasdaq, advancers led decliners by about nearly 2 to 1.
Upvote Downvote

Troymet Completes Sale of 1% NSR Royalty on Key Property to New Gold

2018-04-09 globenewswire
NANAIMO, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- Troymet Exploration Corp. (TSXV:TYE) (“Troymet”) is pleased to announce that it has sold half of its 2% net smelter returns royalty (“NSR Royalty”) on the Key Property (for clarity, the non-repurchasable half of the 2% NSR Royalty was sold) to New Gold Inc. (“New Gold”) for a cash payment received today of $300,000 and a potential future payment of $81,250.
Upvote Downvote

What Mining Stocks’ Relative Strength Index Tells You

2018-04-09 marketrealist
The precious metals and miners were widely expected to react negatively after the Fed decided to hike interest rates.
Upvote Downvote

The Correlations of Miners So Far in 2018

Mining stocks tend to move with gold prices. In this part of the series, we’ll analyze the correlation between gold and these four mining stocks: New Gold (NGD), Newmont Mining (NEM), Agnico-Eagle Mines (AEM), and Franco-Nevada (FNV). Among these miners, Franco-Nevada has the lowest correlation with gold, and Newmont Mining has the highest correlation on a YTD (year-to-date) basis.
Upvote Downvote

5 Gold Stocks to Buy Right Now for Q2

2018-04-02 investorplace
U.S. equities are under serious pressure on Monday, with the S&P 500 finally breaking hard below its 200-day moving average after flirting with that critical technical support level for weeks.
Upvote Downvote

Equinox Gold Releases Fiscal 2017 Financial Results, Appoints General Counsel

2018-04-02 globenewswire
VANCOUVER, British Columbia, April 02, 2018 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX-V:EQX) (OTC:LWLCF) (“Equinox Gold” or “the Company”) has released its audited consolidated financial statements (“Annual Financial Statements”) for the fiscal year ended December 31, 2017. The Annual Financial Statements and accompanying Management’s Discussion and Analysis are available for download on the Company’s website at www.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 644535106